Sort
23,748 grants matching “melanoma”
Cancer Therapeutics through Theory and Experiment: From Cell Lines to Canine Tumors Grown on the Back of Mice
$594,408Aniruddha Datta · Texas A&M Engineering Experiment Station · · FY2019 · ENG
Transcriptional Reprogramming in Melanoma Plasticity
$594,386Chengyu Liang · Wistar Institute · R01 · FY2025 · CA
Ablating Liver Metastases with SBRT to Enhance Immune Checkpoint Blockade in Melanoma
$594,335Michael Daniel Green · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Defining the T-cell Response to Human Renal Cancer
$594,220James C Yang · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
Dissecting Phenotype Switching in Early Stage Melanomas
$594,183Markus Schober · New York University School Of Medicine · R01 · FY2024 · CA
Optimization of a personalized skin cancer risk intervention for at-risk young adults
$594,145Yelena Ping Wu · University Of Utah · R01 · FY2024 · CA
Cancer immunotherapy
$594,136Eytan Ruppin · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
RIG-I Activating Nanoparticles for Immunopotentiation
$594,047John Tanner Wilson · Vanderbilt University · R01 · FY2023 · EB
Cachexia-mediated FcRn Modulation and Its Impact on Anti-PD1 Therapy in Lung Cancer
$594,010Mitch A Phelps · Ohio State University · R01 · FY2024 · CA
Metabolic Engineering for Microbial Taxol Biosynthesis
$593,951Gregory Stephanopoulos · Massachusetts Institute Of Technology · R01 · FY2011 · GM
AIM(2)ing at the inflammasome: Impact of MAVS signaling in cocaine-and HIV-1 induced neuroinflammation
$593,890Irma Cisneros · University Of Texas Med Br Galveston · R01 · FY2025 · DA
AIM(2)ing at the inflammasome: Impact of MAVS signaling in cocaine-and HIV-1 induced neuroinflammation
$593,890Irma Cisneros · University Of Texas Med Br Galveston · R01 · FY2023 · DA
AIM(2)ing at the inflammasome: Impact of MAVS signaling in cocaine-and HIV-1 induced neuroinflammation
$593,890Irma Cisneros · University Of Texas Med Br Galveston · R01 · FY2024 · DA
Pathogenesis of Vascular Anomalies with GNAQ mutations
$593,585Elisa Boscolo · Cincinnati Childrens Hosp Med Ctr · R01 · FY2025 · HL
Risk Factors for Nevus Development in Children
$593,449Lori A Crane · University Of Colorado Denver · R01 · FY2010 · CA
Metabolic Targets in Pten-Tumors
$593,419Jeffrey A Smith · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2012 · CA
Correlative biomarkers of IL-6 blockade combined with checkpoint inhibition
$593,391Jeffrey S Weber · New York University School Of Medicine · R01 · FY2021 · CA
Research Support for Biomedical Careers at CCNY
$593,241Mark L Steinberg · City College Of New York · R25 · FY2007 · GM
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
$593,214Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
$593,214Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Isolation, Characterization, and Behavior of Melanocyte Stem Cells
$593,210Thomas J Hornyak · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Cancer Vaccines and Modulation of Checkpoint Controls in Immunization
$593,182John Janik · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA
Endothelial Toll-like Receptor 3 in the pathogenesis and therapy of Pulmonary Arterial Hypertension
$593,180Laszlo Farkas · Ohio State University · R01 · FY2021 · HL
Novel molecular imaging approaches to monitor gene and cell-based therapies
$593,141Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2012 · CA
Phase II Clinical Development of Galectin-3 Inhibition and Anti-PD-1: Immune Monitoring and Tumor Response
$593,078Brendan D Curti · Providence Portland Medical Center · R01 · FY2021 · CA